News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
551,228 Results
Type
Article (14958)
Company Profile (166)
Press Release (536190)
Multimedia
Podcasts (21)
Webinars (13)
Section
Business (184507)
Career Advice (537)
Deals (27520)
Drug Delivery (29)
Drug Development (61188)
Employer Resources (45)
FDA (11003)
Job Trends (10043)
News (265969)
Policy (20755)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1285)
Accelerated approval (35)
ADA (43)
Adcomms (6)
Allergies (131)
Alliances (38302)
ALS (167)
Alzheimer's disease (1350)
Antibody-drug conjugate (ADC) (341)
Approvals (11629)
Artificial intelligence (538)
ASCO (211)
Autoimmune disease (268)
Automation (43)
Bankruptcy (276)
Best Places to Work (8055)
BIO (48)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (134)
BioSpace Insights (54)
Biotechnology (99)
Bladder cancer (145)
Brain cancer (47)
Breast cancer (630)
Cancer (4657)
Cardiovascular disease (342)
Career advice (470)
Career pathing (19)
CAR-T (226)
CDC (15)
Celiac Disease (1)
Cell therapy (635)
Cervical cancer (40)
Clinical research (54903)
Collaboration (1711)
Commercialization (5)
Compensation (1497)
Complete response letters (42)
COVID-19 (1288)
CRISPR (96)
C-suite (1042)
Cystic fibrosis (118)
Data (7191)
Decentralized trials (1)
Denatured (11)
Depression (134)
Dermatology (80)
Diabetes (490)
Diagnostics (4994)
Digital health (48)
Diversity (3)
Diversity, equity & inclusion (14)
Drug discovery (288)
Drug pricing (26)
Drug shortages (4)
Duchenne muscular dystrophy (213)
Earnings (76941)
Editorial (19)
Employer branding (8)
Employer resources (44)
Events (97637)
Executive appointments (929)
FDA (14108)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (27)
Funding (1352)
Gene editing (173)
Generative AI (42)
Gene therapy (461)
GLP-1 (516)
Government (1703)
Grass and pollen (3)
Guidances (325)
Healthcare (11343)
Hematology (132)
HIV (68)
Huntington's disease (35)
IgA nephropathy (90)
Immunology and inflammation (139)
Immuno-oncology (77)
Indications (182)
Infectious disease (1532)
Inflammatory bowel disease (161)
Inflation Reduction Act (5)
Influenza (103)
Intellectual property (279)
Interviews (78)
IPO (13074)
IRA (9)
Job creations (2366)
Job search strategy (422)
JPM (17)
Kidney cancer (18)
Labor market (19)
Layoffs (148)
Leadership (11)
Legal (5679)
Licensing (9)
Liver cancer (56)
Longevity (26)
Lung cancer (644)
Lymphoma (318)
Machine learning (45)
Management (13)
Manufacturing (685)
Marketing (12)
MASH (154)
Medical affairs (1)
Medical device (9528)
Medtech (9688)
Mergers & acquisitions (15591)
Metabolic disorders (1051)
mRNA (109)
Multiple sclerosis (143)
NASH (8)
Neurodegenerative disease (319)
Neuropsychiatric disorders (63)
Neuroscience (2544)
Neurotech (1)
NextGen: Class of 2026 (3831)
Non-profit (2047)
Now hiring (17)
Obesity (381)
Opinion (106)
Ovarian cancer (181)
Pain (208)
Pancreatic cancer (268)
Parkinson's disease (292)
Partnered (21)
Patents (518)
Patient recruitment (627)
Peanut (40)
People (48662)
Pharmaceutical (38)
Pharmacy benefit managers (8)
Phase 1 (17362)
Phase 2 (24255)
Phase 3 (17077)
Pipeline (8790)
Policy (91)
Postmarket research (1890)
Preclinical (7869)
Press Release (55)
Prostate cancer (226)
Psychedelics (28)
Radiopharmaceuticals (216)
Rare diseases (792)
Real estate (3752)
Recruiting (19)
Regulatory (17260)
Reports (24)
Research institute (1443)
Resumes & cover letters (69)
Rett syndrome (42)
RNA editing (14)
RSV (53)
Schizophrenia (125)
Series A (237)
Series B (153)
Service/supplier (5)
Sickle cell disease (90)
Special edition (3)
Spinal muscular atrophy (121)
Sponsored (25)
Startups (2676)
State (1)
Stomach cancer (5)
Supply chain (65)
Tariffs (6)
The Weekly (9)
Vaccines (522)
Venture capital (56)
Weight loss (166)
Women's health (103)
Worklife (4)
Date
Today (30)
Last 7 days (291)
Last 30 days (1956)
Last 365 days (23194)
2026 (15166)
2025 (22773)
2024 (26581)
2023 (30615)
2022 (39280)
2021 (42351)
2020 (38607)
2019 (28498)
2018 (21487)
2017 (22405)
2016 (21728)
2015 (27826)
2014 (24248)
2013 (20418)
2012 (22261)
2011 (22668)
2010 (21990)
Location
Africa (350)
Alabama (81)
Alaska (5)
Arizona (344)
Arkansas (11)
Asia (22939)
Australia (3103)
California (13034)
Canada (3470)
China (838)
Colorado (526)
Connecticut (516)
Delaware (296)
Europe (42785)
Florida (1914)
Georgia (416)
Hawaii (3)
Idaho (48)
Illinois (846)
India (66)
Indiana (384)
Iowa (21)
Japan (463)
Kansas (115)
Kentucky (35)
Louisiana (49)
Maine (80)
Maryland (1366)
Massachusetts (9027)
Michigan (319)
Minnesota (629)
Mississippi (5)
Missouri (112)
Montana (23)
Nebraska (18)
Nevada (130)
New Hampshire (68)
New Jersey (2984)
New Mexico (26)
New York (3250)
North Carolina (1502)
North Dakota (8)
Northern California (6591)
Ohio (334)
Oklahoma (18)
Oregon (34)
Pennsylvania (2455)
Puerto Rico (27)
Rhode Island (37)
South America (546)
South Carolina (79)
South Dakota (1)
Southern California (5333)
Tennessee (164)
Texas (2128)
United States (43709)
Utah (393)
Vermont (2)
Virginia (208)
Washington D.C. (46)
Washington State (1040)
West Virginia (2)
Wisconsin (99)
Wyoming (1)
551,228 Results for "zeus scientific inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
July 31, 2026
·
3 min read
Press Releases
Zeus Launches PFX™ Platform and Introduces PFX Flex™ Sub-Lite-Wall™, Advancing the Future of Catheter Innovation
January 30, 2026
·
3 min read
Business
Zeus Names Chief Technology Officer
Zeus, a world leader in polymer extrusion and catheter manufacturing, announces the appointment of Suresh Sainath as Chief Technology Officer.
April 22, 2024
·
2 min read
Press Releases
Ambrosia Biosciences Enhances Clinical and Scientific Expertise with Chief Medical Officer and Scientific Advisory Board Appointments
July 28, 2026
·
5 min read
FDA
ZEUS Scientific Announces FDA Clearance for the ZEUS dIFine® IFA Imaging and Pattern Recognition System
The U.S. Food and Drug Administration (FDA) has cleared ZEUS Scientific’s dIFine® digital immunofluorescence system* for use with ZEUS’ ANA HEp-2 indirect fluorescent antibody (IFA) assay.
May 3, 2022
·
2 min read
Press Releases
Milestone Scientific Inc. Completes $2.15 Million Private Placement
April 21, 2026
·
4 min read
Press Releases
Milestone Scientific Reports Financial Results for Second Quarter 2026
August 14, 2026
·
13 min read
Press Releases
Thermo Fisher Scientific Launches Thermo Scientific™ InstaFlux™ to Help Food Microbiology Labs Simplify Workflows in Pathogen and Environmental Testing
July 24, 2026
·
6 min read
Opinion
Extending Scientific Rigor From Bench to Boardroom
Many scientists-turned-CEOs paradoxically abandon scientific principles when it comes to commercializing their innovations. But applying the scientific method to business decisions can help life science entrepreneurs avoid common pitfalls, attract investment and ultimately bring transformative technologies to market.
February 19, 2026
·
6 min read
·
Oded Ben-Joseph
Press Releases
Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
· Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of MetrioPharm AG. · With more than 800 peer-reviewed publications and various prestigious awards, Prof. Braun is internationally recognized as a leading expert in the field of modern clinical and academic rheumatology.
May 26, 2026
·
1 min read
1 of 55,123
Next
